ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,832Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 80

$489K Total Retail Price of All Prescriptions

Rank: 6 out of 80

501 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

11% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 11,115 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 596 560 1 3
METOPROLOL TARTRATE 545 517 2 1
OMEPRAZOLE 433 399 3 24
AMLODIPINE BESYLATE 433 410 3 4
LISINOPRIL 378 323 5 2
ATORVASTATIN CALCIUM 365 361 6 7
LEVOTHYROXINE SODIUM 350 346 7 27
ATENOLOL 324 305 8 9
FUROSEMIDE 287 287 9 5
METFORMIN HCL 285 279 10 42
HYDROCODONE-ACETAMINOPHEN 278 242 S3 11 40
SERTRALINE HCL 264 245 12 47
TRIAMTERENE-HCTZ 255 231 13 44
ZOLPIDEM TARTRATE 253 203 14 50
LOSARTAN POTASSIUM 229 227 15 12
TAMSULOSIN HCL 224 216 16 66
WARFARIN SODIUM 214 214 17 6
METOPROLOL SUCCINATE 211 205 18 8
LOSARTAN-HYDROCHLOROTHIAZIDE 200 199 19 37
DIOVAN 176 176 20 19
DIGOXIN 165 165 21 11
BISOPROLOL-HYDROCHLOROTHIAZIDE 124 124 22 78
FENOFIBRATE 115 103 23 26
ALENDRONATE SODIUM 112 112 24 71
PAROXETINE HCL 111 108 25 94
CARVEDILOL 110 96 26 10
CRESTOR 109 97 27 16
LIPITOR 105 105 28 22
HYDROCHLOROTHIAZIDE 103 103 29 13
AMOXICILLIN 102 97 30 84
QUINAPRIL HCL 101 100 31 33
AZITHROMYCIN 93 84 32 72
AMLODIPINE BESYLATE-BENAZEPRIL 90 90 33 57
ALLOPURINOL 86 84 34 50
LORAZEPAM 86 86 34 88
MECLIZINE HCL 81 78 36 101
ALPRAZOLAM 78 77 37 86
PRAVASTATIN SODIUM 78 75 37 15
CIPROFLOXACIN HCL 78 73 37 103
DIOVAN HCT 71 71 40 46
PLAVIX 69 65 41 20
GLIMEPIRIDE 66 66 42 109
RANITIDINE HCL 66 53 42 65
KLOR-CON M20 65 63 44 34
CLOPIDOGREL 64 57 45 14
POLYETHYLENE GLYCOL 3350 64 64 45 81
METFORMIN HCL ER 62 62 47 85
PANTOPRAZOLE SODIUM 61 48 48 54
PROPRANOLOL HCL 59 55 49 70
ADVAIR DISKUS 58 57 50 75
TRICOR 57 53 51 78
CITALOPRAM HBR 56 50 52 61
DILTIAZEM 24HR ER 51 51 53 18
FINASTERIDE 51 51 53 126
DONEPEZIL HCL 50 50 55 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.